Cel-Sci Corp., of Vienna, Va., and Elkridge, a biotechnology company that is developing new immune system-based treatments for cancer and infectious diseases, said it has received a warning from staff of the New York Stock Exchange that its stock is in danger of being delisted due to noncompliance with the NYSE’s financial condition listing requirement.
Tagged with: biotechnology Business stock exchange vienna virginia
Read More »